menu
    • menu

    Company profile for Normunity

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Normunity, Inc., is a biotechnology company creating a new class of precision immuno-oncology medicines, called immune normalizers, that target novel mechanisms that free the body’s normal immunity against cancer. Based on an ongoing, interactive academic-biotech alliance with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is targeting newly-discovered mechanisms of immune disruption in cancer based on pro...
    Normunity, Inc., is a biotechnology company creating a new class of precision immuno-oncology medicines, called immune normalizers, that target novel mechanisms that free the body’s normal immunity against cancer. Based on an ongoing, interactive academic-biotech alliance with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is targeting newly-discovered mechanisms of immune disruption in cancer based on proprietary discovery platforms that elucidate the complex interactions between human cancer and the immune system.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NormunityUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    520 West Campus Drive West Haven, Connecticut 06477
    Telephone
    Telephone
    203-993-6580
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://normunity.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/normunity/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/normunity

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Normunity Doses First Patient in NRM-823 Phase 1 Trial
    Normunity Doses First Patient in NRM-823 Phase 1 Trial

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181477/0/en/Normunity-announces-first-patient-dosed-in-Phase-1-clinical-study-of-NRM-823-a-T-Cell-Engager-against-a-novel-tumor-specific-target-in-patients-with-solid-tumors.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Fierce Biotech Fundraising Tracker: Umoja, Normunity & more
    Fierce Biotech Fundraising Tracker: Umoja, Normunity & more

    15 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/fierce-biotech-fundraising-tracker-25

    FIERCE BIOTECH
    15 Jan 2025
    Share Share
    Normunity Secures $75M to Advance Anti-Cancer Therapy Pipeline
    Normunity Secures $75M to Advance Anti-Cancer Therapy Pipeline

    13 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250113099228/en

    BUSINESSWIRE
    13 Jan 2025
    Share Share
    Normunity appoints industry leader Debanjan Ray to Board of Directors
    Normunity appoints industry leader Debanjan Ray to Board of Directors

    10 Jul 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230710189247/en

    BUSINESSWIRE
    10 Jul 2023
    Share Share
    Normunity Appoints Olga Granaturova as COO and Chief Business Officer
    Normunity Appoints Olga Granaturova as COO and Chief Business Officer

    19 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230119005216/en

    BUSINESSWIRE
    19 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search